Although SOCS2 has been shown to bind to the IGF1R and decrease its biological actions in vitro15, the ability of SOCS2 to regulate IGF1 signalling in NSCLC remains to be further defined. The gene discussed is SOCS2; the disease is non-small cell lung carcinoma.